Home
Overview
Contents
Executive Summary
Introduction
1 - Alpha Cells
Overview
Breakthrough Needed
No Candidates
Alpha-Cell Focus
No Strategies
New Model
Systems Analysis
Ideal Inhibitor
Supporting Evidence
Transplants
Comments
2 - Amylin Dosing
Overview
Two Hormones
Diurnal Profiles
Basal Amylin
Dysfunctional Dosing
Dosing Solution
Comments
3 - Clinical Research
Clinical Research
Comments
Appendix A
Overview
Introduction
Data Sources
Diurnal Profiles
Healthy Vs T1D
Glycemic Model
Nonglycemic Model
Integrated Model
Comments
Appendix B
Appendix B
Comments
Appendix C
Appendix C
Comments

Amylin Circuit-Breaker

Home
Overview
Contents
Executive Summary
Introduction
1 - Alpha Cells
Overview
Breakthrough Needed
No Candidates
Alpha-Cell Focus
No Strategies
New Model
Systems Analysis
Ideal Inhibitor
Supporting Evidence
Transplants
Comments
2 - Amylin Dosing
Overview
Two Hormones
Diurnal Profiles
Basal Amylin
Dysfunctional Dosing
Dosing Solution
Comments
3 - Clinical Research
Clinical Research
Comments
Appendix A
Overview
Introduction
Data Sources
Diurnal Profiles
Healthy Vs T1D
Glycemic Model
Nonglycemic Model
Integrated Model
Comments
Appendix B
Appendix B
Comments
Appendix C
Appendix C
Comments
Ted Greene
May 18, 2020

Comments on Part 2: Getting the Amylin Dosing Right

Ted Greene
May 18, 2020

Visitors are encouraged to write their comments here. Click on the title to activate the posting window. The author will endeavor to respond directly…

Comment

Click here to download the full report in PDF format.

Back to Top